Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase NA 3 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Successful Conversion Rate of Operation 1 Sarcoma 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Mouth Neoplasms 1 Head and Neck Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Breast Neoplasms, Male 1

Interventions

Cyclophosphamide 5 Positron Emission Tomography Computed Tomography 4 pembrolizumab 3 Topotecan 2 Surveys and Questionnaires 2 Psilocybin 2 Midazolam 2 Methods 2 Ketoconazole 2 Ketamine 2 temsirolimus 1 posaconazole 1 poly ICLC 1 parathyroid hormone-related peptide (1-36) 1 lavender oil 1 jojoba wax 1 ginger extract 1 fluoromisonidazole 1 fludarabine phosphate 1 fludarabine 1 fluciclovine F-18 1 evolocumab 1 etoposide phosphate 1 beta-Glucans 1 Whole-Body Irradiation 1 Vincristine 1 Varenicline 1 Transplantation 1 Transcranial Direct Current Stimulation 1 Tetrahydrouridine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasms × Neoadjuvant Therapy × Clear all

NCT01713218 2012-10-24

NEOPACHI-001

Erasme University Hospital

Phase EARLY_PHASE1 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡